Moreover, when ATRX mutations are present, radiotherapy and temozolomide chemotherapy can induce high PD‐L1 expression in IDH‐mutant glioma cells, further exacerbating inhibition of the immune microenvironment [20] and promoting tumor immune escape. The gene discussed is IDH1; the disease is central nervous system cancer.